Description
Product Overview Naïve CD4+ T cells are negatively selected using a two step isolation process. CD4+ T Cells are first negatively selected from mononucleated cells obtained from leukapharesed blood using an indirect immunomagnetic CD4+ labeling system. CD45RO microbeads are then used to deplete the CD45RO+ population, leaving a highly enriched CD4+ CD45RA+ Naïve T Cell population. Cells are cryopreserved in Lonza Cryo Media in a cryovial. Cell purity is determined post thaw using a FACS assay. Count and viability is determined using hemacytometer (trypan blue method). Cells are collected from healthy donors following IRB protocols. Request More Info
Applications Immunology research Vaccine development Adoptive cell transfer therapy Autoimmune disease research Immunosenescence research
Storage and Content 1 vial containing ≥ 5 million cryopreserved cells